In a bid to strengthen its leadership position in the digestive antacid market in India, GlaxoSmithKline Consumer Healthcare has launched liquid and tablet versions of its Eno brand. So far, Eno has been available only in powder form. Eno's six-tablet pack will be available at Rs 8, while its 170-ml liquid bottle is priced at Rs 68.
‘Eno’ is company’s third-largest brand, after Horlicks and Boost, which together accounted for 80% of the company's turnover of Rs 940 crore in 2012-13. The digestive antacid market in India is estimated at Rs 800 crore, of which powders constitute about 45%.
GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.
Company Name | CMP |
---|---|
Nestle | 2506.20 |
Britannia Inds | 4790.85 |
Varun Beverages | 1485.75 |
Marico | 513.80 |
Hatsun Agro Product | 1094.00 |
View more.. |